top of page


Biotechnology, Life Sciences & Pharma Therapeutics

Our past projects include IP assessment and valuation in the CRISPR (short for Clustered Regularly Interspaced Short Palindromic Repeats) and biopharma therapeutics sectors. 


The CRISPR-cas9 genome editing technique is the 2020 Nobel-winning technology by fellow Berkeley Prof Jennifer Doudna. We are well versed in the CRISPR sphere and have completed projects involving both CRISPR-cas9 and CRISPR-cpf1. Our past projects include assistance to navigate the crowded field of inventors, and through the valuation of IP, mitigated risks and secured significant market share for CRISPR-related therapeutics. 

Biopharma Therapeutics

The biopharmaceutical industry is currently worth US$275billion and sales for therapeutics have approached US$200billion in 2020. We have previously advised a leading Silicon Valley startup through FTO analysis and our reports have assisted this startup to compete with BioPharma giants. Our reports have assisted with further capital injections.


We have assisted with identification of IP, acquisition and licensing of IP. Through IP risk management and strategy, we assist clients to tailor their operations in an otherwise heavily patented landscape. 

Technology, IT & Software

We have extensive experience in the technology, IT and software sector. Past projects include IP risk assessment, IP valuation and analysis relating to:

  • patents relating to the creation of semiconductor chips and devices​

  • methods claimed in software patents against the functionality of IT products

  • patents relating to network security software

F&B Industry, FoodTech & AgriTech

Past projects include brand development, IP strategy and acquisition for a  ​listed company in the alcohol and beverage industry.

We have also assisted investors entering through IP valuation and IP risks assessment in the FoodTech & AgriTech sectors. 

Consumer, Leisure & Luxury

From IP assessment and valuation of patents relating to construction of footwear to implementing strategy of broadening scope of branding protection for leading luxury groups, we are experienced at monetising your IP, and experts at ensuring market position with a unique IP strategy. 

bottom of page